In the Media

News From Columbia Law
In the Media

The media looks to Columbia Law experts to provide ideas, opinions, analysis, and commentary on news of the day. Explore more below.

Find an In the Media Item

Search by Title

Search by Faculty Member Featured

Search by Publisher

Search by Area of Study

Start

End

Topic

Searching by

April 03, 2025 STAT

Pharmaceuticals Are Spared From Tariffs, for Now

Topics: Lina Khan

Featured Faculty: Lina Khan Associate Professor of Law

February 12, 2025 STAT

Gilead’s Short-Term Win Threatens the Future of Pharmaceutical Public-Private Partnerships

Areas of Study: Intellectual Property and Technology
Topics: Christopher Morten; Opinion

January 15, 2025 STAT

Biden Administration and Gilead Settle Long-running Battle Over Patents for HIV PrEP Pills

Areas of Study: Administrative Law and Public Policy; Intellectual Property and Technology
Topics: Christopher Morten; Science, Health, and Information Clinic; Clinics

July 08, 2024 STAT

Biden Administration Appeals Jury Finding in Battle Over Patents for HIV Prevention Pills

Areas of Study: Corporate, Business, and Transactional Law; Intellectual Property and Technology
Topics: Christopher Morten; Science, Health, and Information Clinic; Clinics

September 13, 2023 STAT

In New Regeneron Deal for COVID Drug, White House Imposes Price Limits for First Time

Areas of Study: Administrative Law and Public Policy
Topics: Christopher Morten

August 09, 2023 STAT

Public Pharma Is the Best Solution to the Ongoing Problem of Drug Shortages

Areas of Study: Administrative Law and Public Policy; Intellectual Property and Technology
Topics: Homepage; Christopher Morten

May 02, 2023 STAT

A Battle Between Gilead and the U.S. Government Over Patents on HIV Prevention Pills Goes to Trial

Areas of Study: Constitutional Law; Intellectual Property and Technology
Topics: Christopher Morten

November 12, 2021 STAT

When FDA Rattles Its Sabre, Drug Makers and Universities Start Reporting Overdue Trial Results

Areas of Study: Constitutional Law; Intellectual Property and Technology
Topics: Christopher Morten

August 05, 2021 STAT

A Federal Appeals Court Throws Into Question the Fate of ‘Skinny Labels’—And Access to Generic Drugs

Areas of Study: Intellectual Property and Technology
Topics: Christopher Morten; Clinics; Experiential Learning

July 19, 2021 STAT

Advocates Urge Biden to Name Patent Office Director That Could Transform Drug Pricing

Areas of Study: Constitutional Law; Intellectual Property and Technology
Topics: Christopher Morten; Clinics; Experiential Learning